BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32753671)

  • 1. Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.
    Wouters J; Kalender-Atak Z; Minnoye L; Spanier KI; De Waegeneer M; Bravo González-Blas C; Mauduit D; Davie K; Hulselmans G; Najem A; Dewaele M; Pedri D; Rambow F; Makhzami S; Christiaens V; Ceyssens F; Ghanem G; Marine JC; Poovathingal S; Aerts S
    Nat Cell Biol; 2020 Aug; 22(8):986-998. PubMed ID: 32753671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.
    Verfaillie A; Imrichova H; Atak ZK; Dewaele M; Rambow F; Hulselmans G; Christiaens V; Svetlichnyy D; Luciani F; Van den Mooter L; Claerhout S; Fiers M; Journe F; Ghanem GE; Herrmann C; Halder G; Marine JC; Aerts S
    Nat Commun; 2015 Apr; 6():6683. PubMed ID: 25865119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
    Durand S; Tang Y; Pommier RM; Benboubker V; Grimont M; Boivin F; Barbollat-Boutrand L; Cumunel E; Dupeuble F; Eberhardt A; Plaschka M; Dalle S; Caramel J
    Oncogene; 2024 May; 43(20):1489-1505. PubMed ID: 38519642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells.
    Moscona R; Janssen SM; Elchebly M; Papadakis AI; Rubin E; Spatz A
    Pigment Cell Melanoma Res; 2023; 36(3-4):299-313. PubMed ID: 37082838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.
    Seong I; Min HJ; Lee JH; Yeo CY; Kang DM; Oh ES; Hwang ES; Kim J
    PLoS One; 2012; 7(2):e31477. PubMed ID: 22363655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
    BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
    Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
    J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
    Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
    Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.
    Peretz Y; Wu H; Patel S; Bellacosa A; Katz RA
    PLoS One; 2015; 10(2):e0116839. PubMed ID: 25642713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative network-driven pipeline for systematic identification of lncRNA-associated regulatory network motifs in metastatic melanoma.
    Singh N; Eberhardt M; Wolkenhauer O; Vera J; Gupta SK
    BMC Bioinformatics; 2020 Jul; 21(1):329. PubMed ID: 32703153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment.
    Čermák V; Škarková A; Merta L; Kolomazníková V; Palušová V; Uldrijan S; Rösel D; Brábek J
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
    Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
    Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of long and short enhancers in melanoma cell states.
    Mauduit D; Taskiran II; Minnoye L; de Waegeneer M; Christiaens V; Hulselmans G; Demeulemeester J; Wouters J; Aerts S
    Elife; 2021 Dec; 10():. PubMed ID: 34874265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration.
    Flockhart RJ; Webster DE; Qu K; Mascarenhas N; Kovalski J; Kretz M; Khavari PA
    Genome Res; 2012 Jun; 22(6):1006-14. PubMed ID: 22581800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
    Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
    PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration.
    Lv XB; Wu W; Tang X; Wu Y; Zhu Y; Liu Y; Cui X; Chu J; Hu P; Li J; Guo Q; Cai Z; Wu J; Hu K; Ouyang N
    Oncotarget; 2015 Nov; 6(34):36370-82. PubMed ID: 26461473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.